Abstract
This SOP has been developed to standardise body mass index (BMI) assessment for use in clinical trials.
It represents guidance based upon current best practice.
Local practices for BMI assessment outside of ECFS-CTN activities do not need to be changed in line with this SOP.
PURPOSE
The purpose of this procedure is to develop a standardised, accurate and reproducible method of obtaining BMI measurements from children and adults enrolled in clinical trials within the European Cystic Fibrosis Society Clinical Trial Network (ECFS CTN).
SCOPE
To ensure that ECFS CTN study sites perform BMI measurement in a reproducible and standardised manner. To ensure quality and reliability of the data collected and analysed, each individual site should follow the guidelines described below.
It represents guidance based upon current best practice.
Local practices for BMI assessment outside of ECFS-CTN activities do not need to be changed in line with this SOP.
PURPOSE
The purpose of this procedure is to develop a standardised, accurate and reproducible method of obtaining BMI measurements from children and adults enrolled in clinical trials within the European Cystic Fibrosis Society Clinical Trial Network (ECFS CTN).
SCOPE
To ensure that ECFS CTN study sites perform BMI measurement in a reproducible and standardised manner. To ensure quality and reliability of the data collected and analysed, each individual site should follow the guidelines described below.
| Original language | English |
|---|---|
| Type | ECFS CTN SOP BMI |
| Media of output | Internal Organisation Education PlatformWeb Page |
| Publisher | European Cystic Fibrosis Society |
| Number of pages | 7 |
| Place of Publication | ECFS Education Platform |
| Publication status | Published - 14 Jan 2024 |
Keywords
- BMI
- Cystic fibrosis (CF)
- Clinical Trial
ASJC Scopus subject areas
- General Medicine
- General Health Professions
